Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Enteric coating is a possible cause of aspirin resistance.

Kapoor JR.

J Am Coll Cardiol. 2008 Oct 7;52(15):1276-7; author reply 1277. doi: 10.1016/j.jacc.2008.06.040. No abstract available.

2.

Enteric-coated aspirin and cyclooxygenase inhibition.

Svensson J, Mettinger KL, Blomb├Ąck M.

Thromb Res. 1983 Jan 1;29(1):99-102. No abstract available.

PMID:
6404001
3.

[Effect of enteric-coated tablets of acetylsalicylic acid on platelet function].

Nilsen DW, Thorsen LI, Haga AK, Gamst ON.

Tidsskr Nor Laegeforen. 1986 Jun 10;106(16):1385-7. Norwegian. No abstract available.

PMID:
3750293
4.

Can aspirin act only in the enterohepatic circulation to inactivate platelets?

Brandon RA, Eadie MJ.

Med J Aust. 1987 Sep 7;147(5):261. No abstract available.

PMID:
3670181
5.

In brief: enteric-coated aspirin as an antiplatelet drug.

[No authors listed]

Med Lett Drugs Ther. 2014 Apr 28;56(1441):36. No abstract available.

PMID:
24759295
6.

Aspirin resistance transient laboratory finding or important clinical entity?

Lev EI.

J Am Coll Cardiol. 2009 Feb 24;53(8):678-80. doi: 10.1016/j.jacc.2008.11.018. No abstract available.

7.

Regular and enteric coated aspirin: a reevaluation.

Orozco-Alcala JJ, Baum J.

Arthritis Rheum. 1979 Sep;22(9):1034-7. No abstract available.

PMID:
475872
8.

How reliable are enteric-coated aspirin preparations?

Clark RL, Lasagna L.

Clin Pharmacol Ther. 1965 Sep-Oct;6(5):568-74. No abstract available.

PMID:
5841504
9.

Aspirin resistance: position paper of the Working Group on Aspirin Resistance.

Michelson AD, Cattaneo M, Eikelboom JW, Gurbel P, Kottke-Marchant K, Kunicki TJ, Pulcinelli FM, Cerletti C, Rao AK; Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis; Working Group on Aspirin Resistance.

J Thromb Haemost. 2005 Jun;3(6):1309-11. Epub 2005 May 9. No abstract available.

10.

[Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].

Mani H, Lindhoff-Last E.

Pharm Unserer Zeit. 2009;38(4):342-50. doi: 10.1002/pauz.200900324. Review. German. No abstract available.

PMID:
19572355
11.

Enteric coated aspirin circumventing gastric retention.

Amidon GL, Dressman JB.

J Rheumatol. 1985 Apr;12(2):387-8. No abstract available.

PMID:
4032418
12.

Variability of response to antiplatelet therapy: what should we do next?

Shantsila E, Lip GY.

Fundam Clin Pharmacol. 2009 Feb;23(1):19-22. doi: 10.1111/j.1472-8206.2008.00674.x. No abstract available.

PMID:
19267768
13.

Diagnostics for aspirin resistance.

Gurbel PA, Bilden KP, Tantry US.

Mol Diagn Ther. 2008;12(1):55-6. No abstract available.

PMID:
18288883
14.

Enteric coated aspirin today.

Baum J.

J Rheumatol. 1985 Oct;12(5):829-32. No abstract available.

PMID:
4087264
15.

Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.

Paton TW, Walker SE, Leung FY, Little AH.

Clin Pharm. 1983 Mar-Apr;2(2):165-6. No abstract available.

PMID:
6883946
16.

Single-dose evaluation of a new enteric-coated aspirin preparation.

Page M.

Med J Aust. 1976 Jul 10;2(2):74. No abstract available.

PMID:
979806
17.

Enteric-coated aspirin.

Spruill WJ, Cooper JW Jr.

South Med J. 1983 Feb;76(2):276. No abstract available.

PMID:
6823616
19.

The microspherule concept of enteric coated salicylates.

Tillis HH.

J Med Soc N J. 1966 Sep;63(9):416-7. No abstract available.

PMID:
5231803
20.

Aspirin.

Scopp IW, Roehrl PL.

N Y J Dent. 1979 Aug-Sep;49(7):218-20. No abstract available.

PMID:
287960

Supplemental Content

Support Center